ARTICLE SUMMARY:
Next-generation TMS company NeoSync treats major depressive order with low-field energy applied according to the patient’s individual alpha brain wave frequency, with the goal of achieving efficacy while reducing side effects.
Next-generation TMS company NeoSync treats major depressive order with low-field energy applied according to the patient’s individual alpha brain wave frequency, with the goal of achieving efficacy while reducing side effects.